Stocktoria

IMAC Holdings, Inc. BACK

OTC · stock · Services-Specialty Outpatient Facilities, NEC · website · IPO 2019-02-13 · LEI

IMAC Holdings, Inc. (BACK) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2024 revenue was $72,050 at a -12554.9% net margin.

$0.14 high · $0.00 low · daily closes (~2y) · hover for date & price
10/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 2 3 3 1 2 201920202021202220232024
Altman Z″
-4.42 -4.85 -2.84 -17.50 201920202021202220232024

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.00 as of 2026-09-01 · -99.1% 1y
$0.00$0.1452-wk
Market cap USD$0M
Net margin 5y avg-3196.1%
Return on equity 5y avg-174.4%
Beta1.71
Employees15
Revenue trend · last 6y · down

How it ranks in Services · percentile among 1013 companies

Piotroski Fstronger than 7%
Net marginstronger than 2%
Revenue growthstronger than 0%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
BACKIMAC Holdings, Inc.2/9——-99.6%
EHSIElite Health Systems Inc.2/9-2.64——
CONConcentra Group Holdings Parent, Inc.4/91.2323.2+13.9%
ACHCAcadia Healthcare Company, Inc.5/9——+5%
GOOGAlphabet Inc.5/96.7931.1+15.1%
MSFTMICROSOFT CORP6/94.5920.7+17.8%
METAMeta Platforms, Inc.4/95.3423.1+22.2%

All Services companies →

About IMAC Holdings, Inc.

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

FAQ

Is BACK financially healthy?

IMAC Holdings, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does BACK pay a dividend?

No, IMAC Holdings, Inc. does not currently pay a dividend.

How profitable is BACK?

In FY2024, IMAC Holdings, Inc. had a net margin of -12554.9%.

Is BACK a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on IMAC Holdings, Inc.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.